Meridian Bioscience, Inc. (VIVO)

NASDAQ: VIVO · IEX Real-Time Price · USD
21.25 0.32 (1.53%)
Jan 21, 2022 4:00 PM EST - Market closed

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Oct - Sep.
Year20212020201920182017201620152014201320122011 - 1995
Net Income
71.4146.1924.3823.8521.5632.2335.5434.7438.0333.37
Upgrade
Depreciation & Amortization
15.2913.579.967.928.126.635.225.565.625.66
Upgrade
Share-Based Compensation
4.163.83.253.43.382.913.323.562.51.99
Upgrade
Other Operating Activities
-23.98-15.58-1.42-0.398.3-4.54-1.27-5.6-1.721.43
Upgrade
Operating Cash Flow
66.8747.9836.1834.7941.3637.2242.8138.2644.4442.45
Upgrade
Operating Cash Flow Growth
39.37%32.62%3.99%-15.88%11.10%-13.05%11.88%-13.89%4.69%-
Upgrade
Capital Expenditures
-18.31-3.3-3.13-4.2-4.47-4-3.48-5.31-3.23-3.13
Upgrade
Acquisitions
-23.59-51.3-45.3200-62.090000
Upgrade
Change in Investments
00000-0.60000
Upgrade
Other Investing Activities
1.500000-0.15-1.7-0.04-1.31
Upgrade
Investing Cash Flow
-40.4-54.6-48.45-4.2-4.47-66.7-3.63-7-3.28-4.44
Upgrade
Dividends Paid
00-10.61-21.17-24.27-33.65-33.36-32.76-31.35-31.23
Upgrade
Share Issuance / Repurchase
3.053.560.440.180.32.492.611.012.750.55
Upgrade
Debt Issued / Paid
-8.82-7.1225.09-4.5-3.7558.360000
Upgrade
Other Financing Activities
-25.300-2.11000000
Upgrade
Financing Cash Flow
-31.07-3.5614.92-27.6-27.7127.21-30.74-31.75-28.6-30.67
Upgrade
Net Cash Flow
-3.74-8.881.632.699.85-2.756.93-1.2412.697.97
Upgrade
Free Cash Flow
48.5544.6833.0530.5936.8933.2239.3332.9641.239.32
Upgrade
Free Cash Flow Growth
8.68%35.19%8.05%-17.08%11.04%-15.55%19.35%-20.01%4.80%-
Upgrade
Free Cash Flow Margin
15.27%17.61%16.44%14.32%18.37%16.94%20.19%17.45%21.84%22.76%
Upgrade
Free Cash Flow Per Share
1.121.040.780.720.870.790.940.801.000.96
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).